Patents Assigned to IP LIBERTY VISION CORPORATION
  • Patent number: 11957933
    Abstract: A polymeric radiation-source with customized geometries to maximize receipt of radiation into treatment areas that is formed from either radioisotopes molecularly bonded to a polymer or radioisotopes encased within a polymer.
    Type: Grant
    Filed: August 8, 2022
    Date of Patent: April 16, 2024
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles, Jaime Simon
  • Patent number: 11865360
    Abstract: A method and system may include a therapeutic agent having a radioactive source enclosed by a container. The container may be placed within a cavity of a medical device for treating animal tissue. The method and system allows a radioactive source to be manufactured in such a manner so as to control and spatially modulate the delivery of radiation doses to a treatment area of animal tissue, such as for tissue of humans. From the container, radiation doses and/or a radiation field are produced by the radiation source. The geometry and size of the radiation doses are controlled by the geometry of the container and the geometry of the radiation source as well as the type, number, and geometry of holes/slots in either the source material and/or a surface of the container.
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: January 9, 2024
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles
  • Patent number: 11406843
    Abstract: A polymeric radiation-source with customized geometries to maximize receipt of radiation into treatment areas that is formed from either radioisotopes molecularly bonded to a polymer or radioisotopes encased within a polymer.
    Type: Grant
    Filed: August 18, 2019
    Date of Patent: August 9, 2022
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles, Jaime Simon
  • Patent number: 11045665
    Abstract: An ophthalmic radiation device having a substantially light-transparent wand configured to emit light propagating through the wand light from a series of illumination ports at least partially circumscribing a radioactive source disposed in the holder, thereby providing a visual reference for identifying a position of the radioactive source. Embodiments are directed at effectively directing light from a light source through the body of the wand to illumination ports by using the wand body itself as the light guide. The illumination ports are used as reference points by a medical practitioner to facilitate placing the device into a correct treatment position.
    Type: Grant
    Filed: January 5, 2019
    Date of Patent: June 29, 2021
    Assignee: IP Liberty Vision Corporation
    Inventors: Paul T. Finger, Toby Welles
  • Patent number: 11045351
    Abstract: A light-guided, ophthalmic-treatment-system for administering therapeutic agents to, into or through the scleral wall of the eye globe using any one of a variety of therapeutic applicators in conjunction with either transcorneal or transpupillary viewing methods or both.
    Type: Grant
    Filed: December 31, 2018
    Date of Patent: June 29, 2021
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles
  • Patent number: 11020000
    Abstract: A luminescent ophthalmic device for administering therapeutic materials, the device having at least one luminescent marker disposed in proximity to a therapeutic agent applicator so as facilitate placement in a treatment position when viewed using transcorneal or transpupillary viewing methods.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: June 1, 2021
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles
  • Patent number: 10384078
    Abstract: A polymeric radiation-source with customized geometries to maximize receipt of radiation into treatment areas that is formed from either radioisotopes molecularly bonded to a polymer or radioisotopes encased within a polymer.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: August 20, 2019
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles, Jaime Simon
  • Patent number: 10173075
    Abstract: An ophthalmic radiation device having a substantially light-transparent wand configured to emit light propagating through the wand light from a series of illumination ports at least partially circumscribing a radioactive source disposed in the holder, thereby providing a visual reference for identifying a position of the radioactive source.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: January 8, 2019
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles
  • Patent number: 10166143
    Abstract: A light-guided, ophthalmic-treatment-system for administering therapeutic agents to, into or through the scleral wall of the eye globe using any one of a variety of therapeutic applicators in conjunction with either transcorneal or transpupillary viewing methods or both.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: January 1, 2019
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles
  • Patent number: 10117578
    Abstract: A luminescent ophthalmic device for administering therapeutic materials, the device having at least one luminescent marker disposed in proximity to a therapeutic agent applicator so as facilitate placement in a treatment position when viewed using transcorneal or transpupillary viewing methods.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: November 6, 2018
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles
  • Patent number: 9827444
    Abstract: An ophthalmic radiation device using a polymeric radiation-source implemented as either a polymer molecularly bonded with a radioisotope or a polymeric encasement of a radioisotope.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: November 28, 2017
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles, Jaime Simon
  • Patent number: 9165692
    Abstract: A glass radiation-source with customized geometries to maximize receipt of radiation into treatment areas that is formed from either neutron-activated glass, radioisotopes molecularly bonded to glass, or radioisotopes encased within glass.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: October 20, 2015
    Assignee: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles
  • Publication number: 20150182152
    Abstract: A luminescent ophthalmic device for administering therapeutic materials, the device having at least one luminescent marker disposed in proximity to a therapeutic agent applicator so as facilitate placement in a treatment position when viewed using transcorneal or transpupillary viewing methods.
    Type: Application
    Filed: April 2, 2014
    Publication date: July 2, 2015
    Applicant: IP Liberty Vision Corporation
    Inventors: Paul T. FINGER, Toby Welles
  • Publication number: 20150182725
    Abstract: A light-guided, ophthalmic-treatment-system for administering therapeutic agents to, into or through the scleral wall of the eye globe using any one of a variety of therapeutic applicators in conjunction with either transcorneal or transpupillary viewing methods or both.
    Type: Application
    Filed: April 2, 2014
    Publication date: July 2, 2015
    Applicant: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. FINGER, Toby WELLES
  • Publication number: 20150102238
    Abstract: A glass radiation-source with customized geometries to maximize receipt of radiation into treatment areas that is formed from either neutron-activated glass, radioisotopes molecularly bonded to glass, or radioisotopes encased within glass.
    Type: Application
    Filed: April 2, 2014
    Publication date: April 16, 2015
    Applicant: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. FINGER, Toby WELLES
  • Publication number: 20150105605
    Abstract: An ophthalmic radiation device and method employing a glass radiation-source in which a radioisotope is implemented as either a neutron-activated radioisotope, or radioisotope molecularly bonded to glass or encased in an encasement material.
    Type: Application
    Filed: April 2, 2014
    Publication date: April 16, 2015
    Applicant: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. FINGER, Toby Welles
  • Publication number: 20150105601
    Abstract: An ophthalmic radiation device using a polymeric radiation-source implemented as either a polymer molecularly bonded with a radioisotope or a polymeric encasement of a radioisotope.
    Type: Application
    Filed: April 2, 2014
    Publication date: April 16, 2015
    Applicant: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. Finger, Toby Welles, Jaime Simon
  • Publication number: 20150105602
    Abstract: A polymeric radiation-source with customized geometries to maximize receipt of radiation into treatment areas that is formed from either radioisotopes molecularly bonded to a polymer or radioisotopes encased within a polymer.
    Type: Application
    Filed: April 2, 2014
    Publication date: April 16, 2015
    Applicant: IP LIBERTY VISION CORPORATION
    Inventors: Paul T. FINGER, Toby WELLES, Jaime SIMON